Worried you smell bad? This is the everyday food you should stop eating - and the VERY unexpected ingredient that will banish body odour
That's because your skin releases a mix of scent molecules that's like a personal chemical signature. Even identical twins, who share almost all the same DNA, have their own unique scents.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
23 minutes ago
- The Guardian
UK recovers position in EU's Horizon Europe science research programme
The UK is quickly recovering a prime position in the EU's £80bn science research programme 18 months after becoming a participating member following the resolution of Brexit problems, data shows. The country was frozen out of Horizon Europe for three years in a tit-for-tat row with the then prime minister, Boris Johnson, over the Northern Ireland trading arrangements. While the UK has to play catch-up, entering three years into the seven-year 2020-27 funding programme, data shows British scientists are punching above their weight with €735m (£635m) in grants in 2024. That ranks the UK as the fifth most successful country in the programme, which is open to 43 nations: the 27 EU member states and 16 non-EU associate members also including New Zealand, Canada and Norway. Germany, the top participant in Horizon in 2024, won €1.4bn (£1.21bn) in grants and Spain, which came third, got €900m (£777m). Scientists have said previously they were 'over the moon' to be back working with EU colleagues. They said they knew it would take time to return to the top three because of the time it took to build multinational consortiums to apply for funds. But in terms of grants for proposals by individual scientists, which are easier to assemble, the UK now ranks as the second-most successful participating country after Germany, with €242m (£209m) in funds. The UK is the single most successful applicant country when it comes to Marie Skłodowska-Curie Actions, one of the most prestigious grant programmes for doctoral and post-doctoral research in the world. UK scientists have said repeatedly the Brexit lockout damaged Britain's reputation on the world stage and made it difficult for universities to recruit researchers from the EU. In terms of recipients, the universities of Oxford and Cambridge are neck and neck, with awards of over €65m each, followed by University College London and Imperial College. With projects ranging from the research to develop brain catheters inspired by wasps to efforts to create aviation fuel from yeast and greenhouse gases, the UK has been catapulted to the top of the league of non-EU beneficiaries by number of grants. Sign up to Headlines Europe A digest of the morning's main headlines from the Europe edition emailed direct to you every week day after newsletter promotion Ferdinando Rodriguez y Baena, a professor in medical robotics at Imperial College London recently completed a 15-year Horizon-backed research project creating a cranial catheter inspired by a conversation he had with the renowned zoologist Julian Vincent about wasps' ability to penetrate hard tree bark to lay eggs. Smaller grantees have included individual projects on topics such as textile recycling, conservation and robots on farms. The UK was one of the leading beneficiaries of Horizon, earning more in grants than it contributed in funds before Brexit.
The Independent
an hour ago
- The Independent
Tennis great Monica Seles says she has myasthenia gravis. It is a chronic neuromuscular disease
Monica Seles first noticed the symptoms of myasthenia gravis — a neuromuscular autoimmune disease she discussed during a recent interview with The Associated Press — while she was swinging a racket the way she'd done so many times during, and after, a career that included nine Grand Slam titles and a place in the International Tennis Hall of Fame. 'I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore,' Seles said. 'And, for me, this is when this journey started. And it took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot.' The 51-year-old Seles, who won her first major trophy at age 16 at the 1990 French Open and played her last match in 2003, said she was diagnosed with myasthenia gravis three years ago and is speaking publicly about it for the first time ahead of the U.S. Open, which starts on Aug. 24, to raise awareness about what is known as MG. The National Institute of Neurological Disorders and Stroke calls it 'a chronic neuromuscular disease that causes weakness in the voluntary muscles' and 'most commonly impacts young adult women (under 40) and older men (over 60) but ... can occur at any age, including childhood.' Seles said she'd never heard of the condition until seeing a doctor and being referred to a neurologist after noticing symptoms such as double vision and weakness in her arms — 'just blowing my hair out ... became very difficult,' she said — and legs. 'When I got diagnosed, I was like, 'What?!'' said Seles, who is partnering with argenx, an immunology company headquartered in the Netherlands, to promote their Go for Greater campaign. 'So this is where — I can't emphasize enough — I wish I had somebody like me speak up about it.' It's been three decades since Seles returned to competition at the 1995 U.S. Open, making it to the final, more than two years after she was attacked by a man with a knife at a tournament in Hamburg, Germany. 'The way they welcomed me ... after my stabbing, I will never forget,' Seles said about the fans in New York. 'Those are the moments that stay with you.' She talks about learning to live a 'new normal' nowadays and characterized her health as another in a series of life steps that required adapting. 'I had to, in tennis terms, I guess, reset — hard reset — a few times. I call my first hard reset when I came to the U.S. as a young 13-year-old (from Yugoslavia). Didn't speak the language; left my family. It's a very tough time. Then, obviously, becoming a great player, it's a reset, too, because the fame, money, the attention, changes (everything), and it's hard as a 16-year-old to deal with all that. Then obviously my stabbing — I had to do a huge reset," Seles said. 'And then, really, being diagnosed with myasthenia gravis: another reset. But one thing, as I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust,'' she added. "And that's what I'm doing now.' ___
Daily Mail
an hour ago
- Daily Mail
Going vegan or veggie could slash risk of four top cancer killers by up to 25 per cent, experts discover
Ditching meat and dairy could slash the risk of deadly cancers by up to a quarter, scientists say. A major study of nearly 80,000 people found vegans were 25 per cent less likely to develop cancer than meat eaters—with the diet linked to lower rates of breast cancer and prostate cancer in younger men. Researchers followed members of the Seventh-day Adventist Church in North America for eight years and found vegetarians also cut their cancer risk by 12 per cent. Among this group, rates of colorectal cancer fell by 21 per cent, stomach cancer by 45 per cent and lymphoma by 25 per cent. Lacto-ovo vegetarians—who eat dairy and eggs—had a lower risk of blood cancers, while pescatarians were less likely to get colorectal cancer. The study also revealed that, compared with meat eaters, vegetarians tended to be leaner, drank less alcohol, smoked less and exercised slightly more. They were also less likely to have used oral contraceptives or hormone replacement therapy. While researchers adjusted for these factors, they said it was impossible to rule out that lifestyle differences such as these may have influenced cancer risk. The findings, from scientists at Loma Linda University in California, were published in The American Journal of Clinical Nutrition. It comes amid growing concern over a baffling rise in cancers among young people. A recent global review found rates of colorectal cancer—also known as bowel cancer —in under-50s are climbing in 27 out of 50 countries. England has one of the steepest increases, with cases in younger adults rising by an average of 3.6 per cent a year, while in the US, the rate is going up by around two per cent annually. While bowel cancer is linked to obesity, doctors warn it is also striking fit and healthy patients. Some believe environmental factors—such as exposure to plastics or pollution—could be to blame. Symptoms include abdominal pain, bloating, extreme tiredness, shortness of breath, and a lump in the abdomen. Bleeding from the back passage or blood in the stool can occur when tumours bleed into the digestive tract. However, bowel cancer can also appear with no symptoms until it has spread, making it far harder to treat. Just over half of patients survive 10 years after diagnosis. Other cancers are also on the rise in younger age groups. Rates of metastatic breast cancer—which has spread to other parts of the body—in women under 40 increased by 3.5 per cent a year between 2004 and 2017, according to the Breast Cancer Research Foundation. Lymphoma, a type of blood cancer, is now the most common cancer in young people. A landmark study by Cancer Research UK examining 50 years of NHS data found the risk of developing all cancers has risen sharply, with experts believing a mix of genetic, lifestyle and environmental factors may be driving the trend.
